de Pauw BE - Search Results

1

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: de pauw be. Br J Haematol. 2002 May;117(2):259-64. doi: 10.1046/j.1365-2141.2002.03394.x. Br J Haematol. 2002. PMID: 11972507 Free article. Review. No abstract available.

2

Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: de pauw be. Clin Microbiol Infect. 2001;7 Suppl 4:47-52. doi: 10.1046/j.1469-0691.2001.00058.x. Clin Microbiol Infect. 2001. PMID: 11688534 Free article. Review.

3

Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: de pauw be. Bone Marrow Transplant. 2005 Apr;35(7):707-11. doi: 10.1038/sj.bmt.1704863. Bone Marrow Transplant. 2005. PMID: 15785771

4

Microbiologic consequences of new approaches to managing hematologic malignancies.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: de pauw be. Rev Clin Exp Hematol. 2005 Dec;9(2):E2. Rev Clin Exp Hematol. 2005. PMID: 16864116 Review.

5

Potential sites of infection that develop in febrile neutropenic patients.

Nováková IR, Donnelly JP, De Pauw B. Nováková IR, et al. Leuk Lymphoma. 1993 Aug;10(6):461-7. doi: 10.3109/10428199309148203. Leuk Lymphoma. 1993. PMID: 8401181

6

Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger?

Levenga H, Donnelly P, Blijlevens N, Verweij P, Shirango H, de Pauw B. Levenga H, et al. Ann Hematol. 2004 Jul;83(7):447-9. doi: 10.1007/s00277-003-0831-x. Epub 2003 Dec 19. Ann Hematol. 2004. PMID: 14689234 Review.

7

Options and limitations of teicoplanin in febrile granulocytopenic patients.

De Pauw BE, Novakova IR, Donnelly JP. De Pauw BE, et al. Br J Haematol. 1990 Dec;76 Suppl 2:1-5. doi: 10.1111/j.1365-2141.1990.tb07926.x. Br J Haematol. 1990. PMID: 2149042 Clinical Trial.

8

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy.

de Pauw BE, Raemaekers JM, Donnelly JP, Kullberg BJ, Meis JF. de Pauw BE, et al. Ann Hematol. 1995 Feb;70(2):83-7. doi: 10.1007/BF01834385. Ann Hematol. 1995. PMID: 7880929 Clinical Trial.

9

Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients.

Verweij PE, Donnelly JP, Kullberg BJ, Meis JF, De Pauw BE. Verweij PE, et al. Among authors: de pauw be. Infection. 1994 Mar-Apr;22(2):81-5. doi: 10.1007/BF01739009. Infection. 1994. PMID: 8070935 Clinical Trial.

10

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study.

Vreugdenhil G, Van Dijke BJ, Donnelly JP, Novakova IR, Raemaekers JM, Hoogkamp-Korstanje MA, Koster M, de Pauw BE. Vreugdenhil G, et al. Among authors: de pauw be. Leuk Lymphoma. 1993 Nov;11(5-6):353-8. doi: 10.3109/10428199309067926. Leuk Lymphoma. 1993. PMID: 8124207 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page